Charles + Colvard Ltd. buy krebskrebs
Start price
03.05.22
/
50%
€1.29
Target price
03.05.23
€1.80
Performance (%)
-33.33%
End price
04.05.23
€0.86
Summary
This prediction ended on 04.05.23 with a price of €0.86. Massive losses of -33.33% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Charles + Colvard Ltd. | - | - | - | - |
| iShares Core DAX® | -1,31 % | -0,78 % | 9,15 % | 57,50 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % | 6,57 % | 90,02 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % | 31,58 % | 65,48 % |
| iShares S&P 500 | 1,42 % | -0,48 % | 3,62 % | 62,10 % |
Comments by krebskrebs for this prediction
In the thread Charles + Colvard Ltd. diskutieren
In the thread Trading Charles + Colvard Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten